This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Interventions
The study examined a national programme of universal influenza vaccination in people aged 50 to 64 years. This intervention was compared against the current strategy in which the Australian government only recommends and funds influenza vaccine for those aged at least 65 years and indigenous people aged at least 50 years.
Location/setting
Australia/primary care.
Methods

Analytical approach:
A published decision model on the natural history of influenza was adapted to reflect the Australian setting and to estimate the impact of the vaccination programme. The time horizon of the analysis was 1 year. The authors stated that the perspectives of the analysis were that of the health care payer (including also patient co-payments), that of the government (including only direct costs to Australian governments at federal and state levels), and that of society (which also included lost production costs).
Effectiveness data:
The clinical data used to populate the decision model were presumably derived from a selection of known, relevant studies. The vaccine effectiveness data were retrieved from a published review of influenza vaccines in healthy adults. Other estimates on incidence of disease, proportion of high-risk people, mortality rates and vaccination uptake were mainly derived from national databases. Vaccine uptake under the new policy was based on expert opinion and assumptions. Most of the information on primary sources of clinical data was presented in a companion paper.
Monetary benefit and utility valuations:
Utility valuations were derived from an Australian study (details not give). However, the authors stated that a conservative approach was taken by not applying lower utility weights to the period of illness that individuals may experience for influenza-like illness (ILI) and its complications. Thus, it seems that the utility weights were only related to age groups.
